233 related articles for article (PubMed ID: 1874188)
21. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Dipippo VA; Powers CA
J Pharmacol Exp Ther; 1997 Apr; 281(1):142-8. PubMed ID: 9103491
[TBL] [Abstract][Full Text] [Related]
22. Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats.
Turner RT; Evans GL; Wakley GK
Endocrinology; 1994 Jan; 134(1):461-6. PubMed ID: 7506213
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat.
Pham-Dang ML; Clement R; Mercier I; Calderone A
Can J Physiol Pharmacol; 2003 Sep; 81(9):915-9. PubMed ID: 14614530
[TBL] [Abstract][Full Text] [Related]
24. Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
DiPippo VA; Lindsay R; Powers CA
Endocrinology; 1995 Mar; 136(3):1020-33. PubMed ID: 7867556
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.
Turner RT; Wakley GK; Hannon KS; Bell NH
Endocrinology; 1988 Mar; 122(3):1146-50. PubMed ID: 3342747
[TBL] [Abstract][Full Text] [Related]
26. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen stimulates cancellous bone formation in long bones of female mice.
Perry MJ; Gujra S; Whitworth T; Tobias JH
Endocrinology; 2005 Mar; 146(3):1060-5. PubMed ID: 15576459
[TBL] [Abstract][Full Text] [Related]
28. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.
Shen V; Dempster DW; Birchman R; Xu R; Lindsay R
J Clin Invest; 1993 Jun; 91(6):2479-87. PubMed ID: 8514860
[TBL] [Abstract][Full Text] [Related]
29. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
30. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
Iwamoto J; Seki A; Sato Y
Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
[TBL] [Abstract][Full Text] [Related]
31. 17 beta-estradiol stimulates cancellous bone formation in female rats.
Chow JW; Lean JM; Chambers TJ
Endocrinology; 1992 May; 130(5):3025-32. PubMed ID: 1572310
[TBL] [Abstract][Full Text] [Related]
32. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
33. Effect of chronic administration of tamoxifen and/or estradiol on feeding behavior, palatable food and metabolic parameters in ovariectomized rats.
Lampert C; Arcego DM; Laureano DP; Diehl LA; da Costa Lima IF; Krolow R; Pettenuzzo LF; Dalmaz C; Vendite D
Physiol Behav; 2013 Jul; 119():17-24. PubMed ID: 23688948
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat.
Kalu DN; Salerno E; Liu CC; Echon R; Ray M; Garza-Zapata M; Hollis BW
Bone Miner; 1991 Nov; 15(2):109-23. PubMed ID: 1764629
[TBL] [Abstract][Full Text] [Related]
35. The catechol estrogen, 4-hydroxyestrone, has tissue-specific estrogen actions.
Westerlind KC; Gibson KJ; Evans GL; Turner RT
J Endocrinol; 2000 Nov; 167(2):281-7. PubMed ID: 11054642
[TBL] [Abstract][Full Text] [Related]
36. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption.
Turner RT; Evans GL; Wakley GK
J Bone Miner Res; 1993 Mar; 8(3):359-66. PubMed ID: 8456590
[TBL] [Abstract][Full Text] [Related]
38. Effects of nicotine on bone and calciotropic hormones in aged ovariectomized rats.
Iwaniec UT; Haynatzki GR; Fung YK; Akhter MP; Haven MC; Cullen DM
J Musculoskelet Neuronal Interact; 2002 Sep; 2(5):469-78. PubMed ID: 15758416
[TBL] [Abstract][Full Text] [Related]
39. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.
Diel P; Hertrampf T; Seibel J; Laudenbach-Leschowsky U; Kolba S; Vollmer G
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):60-70. PubMed ID: 17049845
[TBL] [Abstract][Full Text] [Related]
40. Persistent suppression of hepatic CYP2A1 expression and serum triiodothyronine levels by tamoxifen in intact female rats: dose-response analysis and comparison with 4-hydroxytamoxifen, fulvestrant (ICI 182,780), and 17beta-estradiol-3-benzoate.
Ickenstein LM; Bandiera SM
J Pharmacol Exp Ther; 2002 Aug; 302(2):584-93. PubMed ID: 12130719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
